NK cell compartment in patients with coronary heart disease

[1]  A. E. Yeo,et al.  Decreased NK cell frequency in chronic hepatitis C does not affect ex vivo cytolytic killing , 2006, Hepatology.

[2]  J. Ernerudh,et al.  Loss of natural killer cell activity in patients with coronary artery disease. , 2005, Atherosclerosis.

[3]  J. Myśliwska,et al.  Immunomodulating effect of influenza vaccination in the elderly differing in health status , 2004, Experimental Gerontology.

[4]  M. Malavolta,et al.  NK and NKT cell functions in immunosenescence , 2004, Aging cell.

[5]  S. Ouellette,et al.  Chlamydia pneumoniae and atherosclerosis , 2004, Cellular microbiology.

[6]  S. Rubin,et al.  Inflammatory Markers and Onset of Cardiovascular Events: Results From the Health ABC Study , 2003, Circulation.

[7]  L. Jonasson,et al.  Expansion of peripheral CD8+ T cells in patients with coronary artery disease: relation to cytomegalovirus infection , 2003, Journal of internal medicine.

[8]  J. Myśliwska,et al.  Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination--an impact of immunosenescence. , 2003, Vaccine.

[9]  M. Schroll,et al.  Decreased natural killer cell activity is associated with atherosclerosis in elderly humans , 2001, Experimental Gerontology.

[10]  M. Caligiuri,et al.  The biology of human natural killer-cell subsets. , 2001, Trends in immunology.

[11]  D. Streblow,et al.  Do pathogens accelerate atherosclerosis? , 2001, The Journal of nutrition.

[12]  R. Jacobs,et al.  CD56bright cells differ in their KIR repertoire and cytotoxic features from CD56dim NK cells , 2001, European journal of immunology.

[13]  László Kovács,et al.  Natural killer cell cytotoxicity is deficient in newborns with sepsis and recurrent infections , 2001, European Journal of Pediatrics.

[14]  Kayo Nakamura,et al.  Association between natural killer cell activity and infection in immunologically normal elderly people , 2001, Clinical and experimental immunology.

[15]  M. Caligiuri,et al.  Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset , 2001 .

[16]  M. Burnett,et al.  Cytomegalovirus infection increases development of atherosclerosis in Apolipoprotein-E knockout mice. , 2001, Atherosclerosis.

[17]  T. Ghayur,et al.  Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. , 2001, Blood.

[18]  S. Caspar-Bauguil,et al.  Chlamydia pneumoniae induces interleukin-10 production that down-regulates major histocompatibility complex class I expression. , 2000, The Journal of infectious diseases.

[19]  I. Paakkari,et al.  Endothelial Dysfunction After Repeated Chlamydia pneumoniae Infection in Apolipoprotein E–Knockout Mice , 2000, Circulation.

[20]  J. Lansoud-Soukate,et al.  Impairment of natural killer cell activity in Chlamydia trachomatis infected individuals , 1999, Tropical medicine & international health : TM & IH.

[21]  Akuffo,et al.  Natural killer cells in cross‐regulation of IL‐12 by IL‐10 in Leishmania antigen‐stimulated blood donor cells , 1999, Clinical and experimental immunology.

[22]  K. Williams,et al.  Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.

[23]  P. Ghazal,et al.  Murine cytomegalovirus infection down-regulates MHC class II expression on macrophages by induction of IL-10. , 1999, Journal of immunology.

[24]  F. Borrego,et al.  NK phenotypic markers and IL2 response in NK cells from elderly people , 1999, Experimental Gerontology.

[25]  S. Epstein,et al.  The immediate early gene products of human cytomegalovirus increase vascular smooth muscle cell migration, proliferation, and expression of PDGF beta-receptor. , 1999, Biochemical and biophysical research communications.

[26]  J. F. Albright,et al.  Impaired Natural Killer Cell Function as a Consequence of Aging , 1998, Experimental Gerontology.

[27]  P. Morel,et al.  Crossregulation between Th1 and Th2 cells. , 1998, Critical reviews in immunology.

[28]  K. Nakamura,et al.  Natural killer cells in the late decades of human life. , 1997, Clinical immunology and immunopathology.

[29]  A. Essig,et al.  [Chlamydia pneumoniae and atherosclerosis]. , 1997, Deutsche medizinische Wochenschrift.

[30]  J. Myśliwska,et al.  Overactivity of tumor necrosis factor-alpha but not interleukin 6 is associated with low natural killer cytotoxic activity in the elderly. , 1997, Gerontology.

[31]  M. Wilders-Truschnig,et al.  Differential phenotypic properties of human peripheral blood CD56dim+ and CD56bright+ natural killer cell subpopulations. , 1996, International archives of allergy and immunology.

[32]  R. Krishnaraj,et al.  Cytokine sensitivity of human NK cells during immunosenescence. 2. IL2-induced interferon gamma secretion. , 1996, Immunology letters.

[33]  D. Murasko,et al.  Effects of aging on natural killer cell activity and activation by interleukin-2 and IFN-alpha. , 1994, Cellular immunology.

[34]  L. Borysiewicz,et al.  Subsets of CD8 +, CD57+ cells in normal, healthy individuals: correlations with human cytomegalovirus (HCMV) carrier status, phenotypic and functional analyses , 1993, Clinical and experimental immunology.

[35]  M. Passeri,et al.  Lymphocyte subsets and natural killer cell activity in healthy old people and centenarians. , 1993, Blood.

[36]  R. de Waal Malefyt,et al.  Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. , 1993, Journal of immunology.

[37]  B. Autran,et al.  A soluble factor released by CD8+CD57+ lymphocytes from bone marrow transplanted patients inhibits cell-mediated cytolysis. , 1991, Blood.

[38]  M. Vitale,et al.  Age‐associated changes in CD8+ and CD16+ cell reactivity: clonal analysis , 1990, Clinical and experimental immunology.

[39]  R. O. Kelley,et al.  Antibacterial activity of human natural killer cells , 1989, The Journal of experimental medicine.